On the Passing of Former FAS Board Member David Hafemeister
The Federation of American Scientists (FAS) is saddened to learn of the recent death of David Hafemeister, a former FAS Board member who served the organization for 8 years. Dr. Hafemeister was 88 years old.
Hafemeister’s decorated career working on nuclear proliferation and arms control included stints in the office of Senator John Glenn, the State Department, and the National Academy of Sciences (NAS). In 2022, Hafemeister received the University of Illinois Alumni Achievement Award for his work on international arms control.
Daniel Correa, FAS CEO, said “David Hafemeister spent his long and impressive career dedicated to things FAS is still focused on: sound public policy and cutting-edge science. We honor his contributions.”
Steven Aftergood, former director of FAS’ Government Secrecy Project, said “[David] was part of a generation of scientists that took public policy very seriously, and he was deeply involved in nuclear arms control. He worked on the issues from multiple angles — as an advocate (with FAS and APS), as a policy maker at the State Department, and as an influential congressional staffer. I think he represented the heritage of FAS at its best.”
The Federation of American Scientists, founded in 1945, is a catalytic, non-partisan, and nonprofit organization committed to using science and technology to benefit humanity through national security transparency and policy agenda-setting. While continuing its proud tradition of nuclear weapons analysis, FAS now also works to embed science, technology, innovation and experience into a wide range of policy areas to build a healthy, prosperous and equitable society.
Often negotiations between data center developers and local officials are conducted behind closed doors, protected by NDAs. How can we have an informed debate, when we don’t know what’s on the table?
As federal data policy nerds, the question we get asked all the time is “How much data has the current administration terminated?”
Google’s motto famously used to be “don’t be evil.” However, its latest feature has just made being evil a whole lot easier.
The public will judge the next era of American science by the innovation that touches their lives through the new cures, products, and opportunities created within their communities.